AKBLF
Price
$26.50
Change
-$0.00 (-0.00%)
Updated
Sep 30 closing price
VBIZF
Price
$0.14
Change
-$0.00 (-0.00%)
Updated
Oct 4 closing price
Ad is loading...

AKBLF vs VBIZF

Header iconAKBLF vs VBIZF Comparison
Open Charts AKBLF vs VBIZFBanner chart's image
Alk Abello AS
Price$26.50
Change-$0.00 (-0.00%)
Volume$40
CapitalizationN/A
Viva Biotech Holdings
Price$0.14
Change-$0.00 (-0.00%)
Volume$1K
CapitalizationN/A
View a ticker or compare two or three
AKBLF vs VBIZF Comparison Chart
Loading...
VS
AKBLF vs. VBIZF commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKBLF is a Sell and VBIZF is a Sell.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (AKBLF: $25.13 vs. VBIZF: $0.14)
Brand notoriety: AKBLF and VBIZF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKBLF: 1% vs. VBIZF: 343%
Market capitalization -- AKBLF: $5.69B vs. VBIZF: $261.35M
AKBLF [@Biotechnology] is valued at $5.69B. VBIZF’s [@Biotechnology] market capitalization is $261.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKBLF’s FA Score shows that 0 FA rating(s) are green whileVBIZF’s FA Score has 1 green FA rating(s).

  • AKBLF’s FA Score: 0 green, 5 red.
  • VBIZF’s FA Score: 1 green, 4 red.
According to our system of comparison, AKBLF is a better buy in the long-term than VBIZF.

Price Growth

AKBLF (@Biotechnology) experienced а -5.19% price change this week, while VBIZF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
AKBLF($5.69B) has a higher market cap than VBIZF($261M). AKBLF YTD gains are higher at: 89.623 vs. VBIZF (11.710).
AKBLFVBIZFAKBLF / VBIZF
Capitalization5.69B261M2,181%
EBITDA1.18BN/A-
Gain YTD89.62311.710765%
P/E Ratio55.25N/A-
Revenue5.18BN/A-
Total Cash420MN/A-
Total Debt507MN/A-
FUNDAMENTALS RATINGS
AKBLF: Fundamental Ratings
AKBLF
OUTLOOK RATING
1..100
97
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
39
SMR RATING
1..100
57
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

AKBLF and

Correlation & Price change

A.I.dvisor tells us that AKBLF and MNPR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKBLF and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKBLF
1D Price
Change %
AKBLF100%
N/A
MNPR - AKBLF
29%
Poorly correlated
+8.56%
MSCLF - AKBLF
28%
Poorly correlated
+17.17%
VBIZF - AKBLF
26%
Poorly correlated
N/A
IOVA - AKBLF
25%
Poorly correlated
+8.54%
SMMT - AKBLF
25%
Poorly correlated
-8.06%
More

VBIZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VBIZF has been loosely correlated with SMMT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VBIZF jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VBIZF
1D Price
Change %
VBIZF100%
N/A
SMMT - VBIZF
42%
Loosely correlated
-8.06%
BCLI - VBIZF
35%
Loosely correlated
+11.47%
AKBLF - VBIZF
26%
Poorly correlated
N/A
ACHL - VBIZF
24%
Poorly correlated
N/A
WXXWY - VBIZF
4%
Poorly correlated
-3.81%
More